HAIR-AN Syndrome Associated with Scleroderma
DOI:
https://doi.org/10.12970/2310-9874.2015.03.01.3Keywords:
HAIR-AN, syndrome, sclerodermaAbstract
The HAIR-AN syndrome is a rare multisystem disorder in women, that consists of hyperandrogenism (HA), insulin resistance (IR) and acanthosis nigricans (AN). The IR is likely due to a primary defect of the insulin receptor. We report the case of a 25-year-old Caucasian woman with HAIR-AN syndrome, impaired glucose tolerance (IGT), mild hyperlipemia, and hypertension, associated with sclerodermatous skin changes on the extremities and trunk. Though scleroderma may coexist with other autoimmune diseases, its presentation with HAIR-AN syndrome has not yet been described.
References
Barbieri RL, Ryan KJ. Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: a common endocrinopathy with distinct pathophysiologic features. Am J Obstet Gynecol 1983; 147: 90-101.
Esperanza LE, Fenske NA. Hyperandrogenism, insulin resistance, and acanthosis nigricans (HAIR-AN) syndrome: spontaneous remission in a 15-year-old girl. J Am Acad Dermatol 1996; 34: 892-7. http://dx.doi.org/10.1016/S0190-9622(96)90074-2
Arnett FC, Cho M, Chatterjee S, Aguilar MB, Reveille JD, Mayes MD. Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis Rheum 2001; 44: 1359-1362. http://dx.doi.org/10.1002/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S
Krieg T, Takehara K. Skin disease: a cardinal feature of systemic sclerosis. Rheumatology 2009; 48: 14-18. http://dx.doi.org/10.1093/rheumatology/kep108
Mayes MD. Scleroderma epidemiology. Rheum Dis Clin North Am 1996; 22: 751-764. http://dx.doi.org/10.1016/S0889-857X(05)70299-4
Shen Z, Hao F, Wei P. HAIR-AN syndrome in a male adolescent with concomitant vitiligo. Arch Dermatol 2009; 145(4): 492-4. http://dx.doi.org/10.1001/archdermatol.2009.12
Rooney DP, Ryan MF. Diabetes with partial lipodystrophy following sclerodermatous chronic graft vs. host disease. Diabet Med 2006; 23(4): 436-40. http://dx.doi.org/10.1111/j.1464-5491.2006.01855.x
Bloise W, Wajchenberg BL, Moncada VY, Marcus-Samuels B, Taylor SI. Atypical antiinsulin receptor antibodies in a patient with type B insulin resistance and scleroderma. J Clin Endocrinol Metab 1989; 68(1): 227-31. http://dx.doi.org/10.1210/jcem-68-1-227
Fett N. Scleroderma: nomenclature, etiology, pathogenesis, prognosis, and treatments: facts and controversies. Clin Dermatol 2013; 31(4): 432-7. http://dx.doi.org/10.1016/j.clindermatol.2013.01.010
